0001415889-24-016354.txt : 20240611 0001415889-24-016354.hdr.sgml : 20240611 20240611161500 ACCESSION NUMBER: 0001415889-24-016354 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliger Christy J. CENTRAL INDEX KEY: 0001822092 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40407 FILM NUMBER: 241035929 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SUITE 210 CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vera Therapeutics, Inc. CENTRAL INDEX KEY: 0001831828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812744449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-770-0077 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD, SUITE 120 CITY: BRISBANE STATE: CA ZIP: 94005 3 1 form3-06112024_080657.xml X0206 3 2024-06-07 0 0001831828 Vera Therapeutics, Inc. VERA 0001822092 Oliger Christy J. C/O VERA THERAPEUTICS, INC. 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 true false false false Class A Common Stock 2987 D Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. The RSUs are fully vested as to service and shall settle on a date in 2025, as determined by the Issuer. /s/ Joseph R. Young, Attorney-in-Fact 2024-06-11 EX-24 2 ex24-06112024_080601.htm ex24-06112024_080601.htm

POWER OF ATTORNEY



KNOW ALL BY THESE PRESENTS that the undersigned hereby constitutes and appoints each of Joseph R. Young and Sean Grant of Vera Therapeutics, Inc. (the "Company"), signing individually, the undersigned’s true and lawful attorneys-in-fact and agents to:


1.

execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or more than 10% stockholder of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended and the rules thereunder;


2.

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such form with the U.S. Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and


3.

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorneyin-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneyin-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorneyin-fact's discretion.


The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.


This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact individually, until such attorney-in-fact is no longer employed by the Company.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day of June 2024.



/s/ Christy J. Oliger


Christy J. Oliger